EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:756510 - risankizumab
| ChEBI ID | CHEBI:756510 |
| ChEBI Name | risankizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| Roles Classification |
|---|
| Biological Role: | antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. anti-asthmatic agent Any compound that has anti-asthmatic effects. antipsoriatic A drug used to treat psoriasis. anti-inflammatory agent Any compound that has anti-inflammatory effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| risankizumab (CHEBI:756510) has role anti-asthmatic agent (CHEBI:65023) |
| risankizumab (CHEBI:756510) has role anti-inflammatory agent (CHEBI:67079) |
| risankizumab (CHEBI:756510) has role antipsoriatic (CHEBI:50748) |
| risankizumab (CHEBI:756510) has role antiviral agent (CHEBI:22587) |
| risankizumab (CHEBI:756510) has role dermatologic drug (CHEBI:50177) |
| risankizumab (CHEBI:756510) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| 655066-01 | ChEMBL |
| ABBV-066 | ChEMBL |
| Bi-655066 | ChEMBL |
| BI655066 | ChEMBL |
| Risankizumab | ChEMBL |
| Risankizumab rzaa | ChEMBL |
| Brand Name | Source |
|---|---|
| Skyrizi | ChEMBL |